Toronto Dominion Bank’s SpringWorks Therapeutics SWTX Stock Holding History

Toronto Dominion Bank’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-57,903	Closed	-$2.72M	–	2088
2025 Q2	$2.72M	Sell	57,903 -12,107	-17%	-$539K	﹤0.01%	888
2025 Q1	$3.09M	Buy	+70,010	New	+$3.22M	0.01%	814
2022 Q1	–	Sell	-23,882	Closed	-$1.48M	–	1952
2021 Q4	$1.48M	Buy	+23,882	New	+$1.58M	﹤0.01%	923

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Toronto Dominion Bank's SWTX Position: Q3 2025 in Review

Toronto Dominion Bank sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 57,903 shares — an estimated $2.72M sold.

Toronto Dominion Bank first reported a position in SWTX in Q4 2021 and held it in 3 quarters. The position peaked at $3.09M in Q1 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Toronto Dominion Bank reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Toronto Dominion Bank sold 57,903 SpringWorks Therapeutics shares in Q3 2025, an estimated $2.72M.
Toronto Dominion Bank first reported a position in SpringWorks Therapeutics in Q4 2021 and held it in 3 quarters.
Toronto Dominion Bank's SpringWorks Therapeutics position peaked at $3.09M in Q1 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Toronto Dominion Bank's 13F filing for Q3 2025, filed 14 Nov 2025.